Interaction Guide · Research summary

Can I take Hyoscyamus Niger with Doxylamine?

Review Hyoscyamus Niger with Doxylamine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Henbane containing active anticholinergic alkaloids may add to doxylamine side effects such as confusion, dry mouth, constipation or urinary retention. Do not add such a product without clinician review.

What this answer covers

Hyoscyamus niger preparations containing active tropane alkaloids.

Supplement or preparation
Hyoscyamus niger
Medication ingredient
doxylamine

Why the effects could add up

Doxylamine has anticholinergic or atropine-like effects. Active plant alkaloids can affect the same functions, making bowel, bladder, vision and mental-state symptoms relevant.

What the human report establishes

The original report describes plant poisoning in children, with anticholinergic symptoms. It supports concern about active plant material, but does not measure this medicine combination or the risk at an adult supplement dose.

The product identity matters

Plant part, extraction and concentration affect alkaloid exposure. A highly diluted product and an active herbal preparation cannot be assumed equivalent, and no reliable pair-specific dose threshold was established. OTC doxylamine sleep tablets and the delayed-release doxylamine/pyridoxine product for pregnancy nausea have different purposes and schedules. Their doxylamine effects are relevant, but the formulations are not interchangeable.

Act on symptoms rather than guessing a gap

Have the exact product checked before use. A short timing gap is not an established way to prevent overlapping effects. Seek urgent care for marked confusion, inability to urinate, severe abdominal swelling or pain, or a painful red eye with vision change.

Evidence and practical considerations

Side effects & toxicity

Conditional additive anticholinergic concern for active-alkaloid products, based on exact medication effects and original plant toxicity. No exact-pair event rate or safe dose established.

Exact scope
Hyoscyamus niger preparations containing active tropane alkaloids. with Oral doxylamine succinate sleep-aid tablets; delayed-release doxylamine/pyridoxine pregnancy product considered separately.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.

Factors that may matter: Preparation; Dose; Other medicines; Organ function.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed doxylamine

Ask doctor/pharmacist before other sedatives or sleep aids; do not drive; use only at bedtime with a full night available.

How this applies: Exact doxylamine RxCUI 3642 IN, with stated salt/formulation/route bridge.

No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed doxylamine

Delayed-release doxylamine succinate/pyridoxine hydrochloride pregnancy product: somnolence due to doxylamine; CNS-depressant co-use not recommended, anticholinergic precautions.

How this applies: Exact doxylamine RxCUI 3642 IN, with stated salt/formulation/route bridge.

Same active ingredient, different formulation or combination. Product-specific results cannot be transferred as identical exposure.

Source 3: Original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Sixty-eight children admitted after Hyoscyamus niger poisoning.

Antimuscarinic toxicity included agitation, pupil changes and severe neurologic effects in some children.

How this applies: Interpreted for doxylamine only within the stated exact preparation and endpoint limits.

Pediatric plant poisoning, not an exact doxylamine co-use study or a normal adult supplement risk estimate.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Research summary published
Article prepared
Prepared exact doxylamine article with formulation-specific evidence and uncertainty.

Article revision: 19e8227fbe5ff77a

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.